ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunogenicity"

  • 2016 American Transplant Congress

    Potent Induction Therapy Improves Graft Outcome in Younger Pancreas Transplant Recipients (<30 Years of Age).

    A. Gruessner, V. Whittaker, S. Narsipur, V. Aggarwal, C. Hubbel, R. Gruessner.

    SUNY Upstate Medical University, Syracuse, NY.

    Purpose: Pancreas transplants (tx) are increasingly performed in older patients with type 1 diabetes mellitus. This trend may be explained by the significantly higher immunologic…
  • 2016 American Transplant Congress

    Assessing Return of CMV Specific Cellular Immunity Using the T-SPOT.CMV Soon After Kidney Transplant with Thymoglobulin.

    C. Kotton.

    Infectious Disease, Massachusetts General Hospital, Boston, MA.

    Background: We do not currently have sufficient predictive tools to determine risk of CMV infection after organ transplantation. Recent data suggest that assays of the…
  • 2016 American Transplant Congress

    Differential Regulation of the Microvascular Endothelial Cell Mediated Allogeneic CD4+ T Cell Response by Anti-HLA-DR and -DQ Alloantibodies in an Inflammatory Context.

    N. Mooney,1,2 A. Cross,1,2 J. Lion,1,2 A. Haziot,1,2 D. Glotz.1,2,3

    1INSERM UMRS 1160, Institut Universitaire d'Hématologie, Paris, France; 2Université-Paris-Diderot, Sorbonne Paris Cité, Paris, France; 3Service de Néphrologie et Transplantation, Hôpital Saint Louis, Paris, France.

    This study examines the basic mechanisms by which high levels of circulating HLA class II donor-specific-antibodies can contribute to microvasculature damage in chronic antibody mediated…
  • 2016 American Transplant Congress

    Blocking MHC Class II on Human Endothelium Mitigates Acute Rejection of Vessel Allografts by Effector Memory T Cells.

    P. Abrahimi,1 L. Qin,2 W. Chang,1 A. Bothwell,1 G. Tellides,2 W. Saltzman,3 J. Pober.1

    1Immunobiology, Yale School of Medicine, New Haven, CT; 2Surgery, Yale School of Medicine, New Haven, CT; 3Biomedical Engineering, Yale University, New Haven, CT.

    Acute allograft rejection is mediated by alloreactive CD8+ T cells that differentiate into cytotoxic lymphocytes (CTL). In most rodent models, CTL differentiate from naïve CD8+…
  • 2016 American Transplant Congress

    Everolimus in Combination with Reduced Dose Tacrolimus Is Effective as a Prophylaxis of Acute Rejection in Low-to-Moderate Immunologic Risk De Novo Kidney Transplantation Patients.

    Y. Qazi, F. Shihab, S. Mulgaonkar, K. MaCague, D. Patel.

    University of Southern California, Los Angeles; University of Utah, Salt Lake City; Barnabas Health, West Orange; Novartis Pharmaceuticals Corporation, East Hanover.

    The US92 study determined whether, in de novo renal transplant patients (pts), concentration-controlled everolimus (EVR) with reduced dose tacrolimus (RTAC) is non-inferior compared to CellCept®…
  • 2016 American Transplant Congress

    Delayed Induction of Mixed Chimerism Permits Kidney-Induced Cardiac Allograft Tolerance to be Applied to Recipients of Cadaveric Organs.

    M. Tonsho,1 G. Benichou,1 R. Yu,1 S. Boskovic,1 R. Colvin,1,2 E. Farkash,2 R.-N. Smith,2 J. Allan,1,4 A. Cosimi,1 T. Kawai,1,3 J. Madsen.1,4

    1Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA; 2Department of Pathology, Massachusetts General Hospital, Boston, MA; 3Department of Surgery, Massachusetts General Hospital, Boston, MA; 4Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA.

    (BACKGROUND)Cardiac tolerance in nonhuman primates (NHPs) has been induced for the first time by kidney co-transplantation in combination with donor bone marrow infusion when the…
  • 2015 American Transplant Congress

    Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients

    D. Kumar,1 P. Campbell,2 K. Hoschler,3 A. Humar.1

    1Univ Health Network, Toronto, Canada; 2Univ of Alberta, Edmonton, Canada; 3Public Health England, London, United Kingdom.

    Background:Influenza vaccine is known to have suboptimal immunogenicity in transplant recipients. However, influenza vaccine may have the added benefit of inducing a cross-reactive immune response…
  • 2015 American Transplant Congress

    Assessing Pre-Vaccination Cytokine Levels to Predict Immunogenicity to Seasonal Trivalent Influenza Vaccine in Solid Organ Transplant Recipients

    M. Fernandez-Ruiz, A. Humar, S. Keshwani, S. Husain, D. Kumar.

    Multi-Organ Transplant Program, University Health Network, Toronto, Canada.

    Background: The immunogenicity of seasonal trivalent influenza vaccine (TIV) in solid organ transplant (SOT) recipients remains suboptimal. We hypothesized that analysis of pre-vaccination T- and…
  • 2015 American Transplant Congress

    Immune Rejection of iPS Cells Is Triggered By Gamete-Associated Proteins (GAPs)

    E.-M. Kim, G. Manzar, N. Zavazava.

    Internal Medicine, University of Iowa, Iowa City, IA; Internal Medicine, University of Iowa, Iowa City, IA; Internal Medicine, University of Iowa, Iowa City, IA.

    Induced pluripotent stem (iPS) cells have emerged as a new source for cell based therapies. However, the safety of iPS cells in autologous recipients has…
  • 2015 American Transplant Congress

    Identifying Barriers Specific to Xenoislets by Direct Comparison to Alloislets in a Dual Transplant Model

    K. Samy,1 B. Martin,2 P. Thompson,2 A. Farris,2 M. Song,2 V. Leopardi,1 B. Collins,1 A. Kirk.1

    1Department of Surgery, Duke University Medical Center, Durham, NC; 2Emory Transplant Center, Emory University, Atlanta, GA.

    Purpose:The xenotransplantation of neonatal porcine islets (NPIs) may alleviate the shortage of islets currently limiting islet allotransplantation. However, successful implementation requires understanding of the immune…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences